Centron Diagnostics sells Central Blood Pressure Technology to SunTech Medical
Centron Diagnostics, a spin-out company from King's College London, has sold its central blood pressure monitoring technology and assets to SunTech Medical Inc, a global leader in clinical-grade, non-invasive blood pressure measurement solutions.
The technology was developed through research at King's College London and commercialised via Centron and will now be available to health care workers and patients through the sale to SunTech.
There can be significant clinical differences between central blood pressure at the heart and traditional arm blood pressure readings, ultimately impacting patient management. Recent evidence suggests central blood pressure to be a better measure to detect damage to the heart and arteries than arm blood pressure. Further, for similar reduction in arm blood pressure, treatments that preferentially lower central blood pressure provide greater protection from serious complications of hypertension.
Centron has shown that it is possible to take methodology developed in the research laboratory and turn it into a product that produces reliable automated central blood pressure readings in the clinical setting at low cost.
Centron Diagnostics was spun out of King's College London in July 2010 with investment from its founders and from Guy's and St Thomas' Charity. King's College London licenced the patented technology to Centron Diagnostics for development and commercialisation, supporting the company in its early stages whilst retaining a shareholding. Certain of the underpinning research was funded by the British Heart Foundation.
30 July 2014
About King's College London
King's College London is one of the top 20 universities in the world (2013/14 QS World University Rankings) and the fourth oldest in England. It is The Sunday Times 'Best University for Graduate Employment 2012/13'. A research-led university based in the heart of London, King's has more than 25,000 students (of whom more than 10,000 are graduate students) from nearly 140 countries, and more than 6,500 employees. King's has an outstanding reputation for providing world-class teaching and cutting-edge research. In the 2008 Research Assessment Exercise for British universities, 23 departments were ranked in the top quartile of British universities; over half of their academic staff work in departments that are in the top 10 per cent in the UK in their field and can thus be classed as world leading. The College is in the top seven UK universities for research earnings and has an overall annual income of nearly £554 million.
About Guy's and St Thomas' Charity
Guy's and St Thomas' Charity is a catalyst for health and healthcare improvement in Lambeth and Southwark. It supports innovation in order to create world-leading healthcare in Guy's and St Thomas' NHS Foundation Trust; to improve the physical and mental health of the local population; and to fulfil the vision of King's Health Partners. The Charity plays an important role in providing early stage funding for health advances with commercial potential.
About SunTech Medical
SunTech Medical, a subsidiary of Halma plc, has been the preeminent supplier of clinical-grade blood pressure monitoring products and technology for nearly 30 years. More than 100 medical device companies trust SunTech Medical's OEM non-invasive blood pressure solutions for their patient monitoring needs. SunTech Medical delivers the leading cardiac stress test blood pressure monitor and is the world's foremost manufacturer of ambulatory blood pressure monitoring products. SunTech Medical also offers solutions for in-office blood pressure monitoring as well as a complete line of blood pressure cuffs designed for general and specific applications. SunTech Medical's press release about its acquisition of Centron's central blood pressure technology is at SunTech Medical Acquires Central Blood Pressure Technology from Centron Diagnostics Press Ralese